{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T14:06:40Z","timestamp":1762438000120,"version":"build-2065373602"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Technology Dissemination and Optimization Management Program of Shanghai Shenkang Hospital Development Center","award":["SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202"],"award-info":[{"award-number":["SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202","SHDC22025202"]}]},{"name":"Clinical Research Program of Zhongshan Hospital, Fudan University","award":["2023ZSLC63","2023ZSLC63","2023ZSLC63"],"award-info":[{"award-number":["2023ZSLC63","2023ZSLC63","2023ZSLC63"]}]},{"name":"Science and Technology Innovation Fund of Zhongshan Hospital, Fudan University","award":["2024ZSCX08","2024ZSCX08","2024ZSCX08"],"award-info":[{"award-number":["2024ZSCX08","2024ZSCX08","2024ZSCX08"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32571067"],"award-info":[{"award-number":["32571067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-025-01716-0","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T14:04:08Z","timestamp":1762437848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-grade uterine endometrial stromal sarcoma harboring GLI1 and MDM2\/CDK4 co-amplifications"],"prefix":"10.1186","volume":"20","author":[{"given":"Lili","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Luan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieakesu","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"1716_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/332371a0","volume":"332","author":"KW Kinzler","year":"1988","unstructured":"Kinzler KW, Ruppert JM, Bigner SH, et al. The GLI gene is a member of the kruppel family of zinc finger proteins. Nature. 1988;332:371\u20134. https:\/\/doi.org\/10.1038\/332371a0","journal-title":"Nature"},{"key":"1716_CR2","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0002-9297(07)62934-6","volume":"67","author":"EH Villavicencio","year":"2000","unstructured":"Villavicencio EH, Walterhouse DO, Iannaccone PM. The sonic hedgehog-patched-gli pathway in human development and disease. Am J Hum Genet. 2000;67:1047\u201354. https:\/\/doi.org\/10.1016\/S0002-9297(07)62934-6","journal-title":"Am J Hum Genet"},{"key":"1716_CR3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/PAS.0000000000001844","volume":"46","author":"P Argani","year":"2022","unstructured":"Argani P, Boyraz B, Oliva E, et al. GLI1 gene alterations in neoplasms of the genitourinary and gynecologic tract. Am J Surg Pathol. 2022;46:677\u201387. https:\/\/doi.org\/10.1097\/PAS.0000000000001844","journal-title":"Am J Surg Pathol"},{"key":"1716_CR4","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00428-021-03224-0","volume":"480","author":"J Liu","year":"2022","unstructured":"Liu J, Mao R, Lao IW, et al. GLI1-altered mesenchymal tumor: a clinicopathological and molecular analysis of ten additional cases of an emerging entity. Virchows Arch. 2022;480:1087\u201399. https:\/\/doi.org\/10.1007\/s00428-021-03224-0","journal-title":"Virchows Arch"},{"key":"1716_CR5","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/s0002-9440(10)63723-6","volume":"164","author":"A Dahlen","year":"2004","unstructured":"Dahlen A, Fletcher CD, Mertens F, et al. Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). Am J Pathol. 2004;164:1645\u201353. https:\/\/doi.org\/10.1016\/s0002-9440(10)63723-6","journal-title":"Am J Pathol"},{"key":"1716_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/(SICI)1098-2264(200006)28:2<220::AID-GCC11>3.0.CO;2-T","volume":"28","author":"AT Gordon","year":"2000","unstructured":"Gordon AT, Brinkschmidt C, Anderson J, et al. A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma. Genes Chromosomes Cancer. 2000;28:220\u20136.","journal-title":"Genes Chromosomes Cancer"},{"key":"1716_CR7","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41379-019-0293-x","volume":"32","author":"NP Agaram","year":"2019","unstructured":"Agaram NP, Zhang L, Sung YS, et al. GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions. Mod Pathol. 2019;32:1617\u201326. https:\/\/doi.org\/10.1038\/s41379-019-0293-x","journal-title":"Mod Pathol"},{"key":"1716_CR8","doi-asserted-by":"publisher","first-page":"100494","DOI":"10.1016\/j.modpat.2024.100494","volume":"37","author":"AE Sharma","year":"2024","unstructured":"Sharma AE, Dickson M, Singer S, et al. GLI1 coamplification in well-differentiated\/dedifferentiated liposarcomas: clinicopathologic and molecular analysis of 92 cases. Mod Pathol. 2024;37:100494. https:\/\/doi.org\/10.1016\/j.modpat.2024.100494","journal-title":"Mod Pathol"},{"key":"1716_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/gcc.20835","volume":"50","author":"WD Tap","year":"2011","unstructured":"Tap WD, Eilber FC, Ginther C, et al. Evaluation of well-differentiated\/de-differentiated liposarcomas by high-resolution oligonucleotide array-based comparative genomic hybridization. Genes Chromosomes Cancer. 2011;50:95\u2013112. https:\/\/doi.org\/10.1002\/gcc.20835","journal-title":"Genes Chromosomes Cancer"},{"key":"1716_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13039-017-0325-5","volume":"10","author":"N Mandahl","year":"2017","unstructured":"Mandahl N, Magnusson L, Nilsson J, et al. Scattered genomic amplification in dedifferentiated liposarcoma. Mol Cytogenet. 2017;10:25. https:\/\/doi.org\/10.1186\/s13039-017-0325-5","journal-title":"Mol Cytogenet"},{"key":"1716_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10153230","author":"J Nishio","year":"2021","unstructured":"Nishio J, Nakayama S, Nabeshima K, et al. Biology and management of dedifferentiated liposarcoma: state of the art and perspectives. J Clin Med 10. 2021. https:\/\/doi.org\/10.3390\/jcm10153230","journal-title":"J Clin Med 10"},{"key":"1716_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/path.2564","volume":"218","author":"EL Snyder","year":"2009","unstructured":"Snyder EL, Sandstrom DJ, Law K, et al. c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme. J Pathol. 2009;218:292\u2013300. https:\/\/doi.org\/10.1002\/path.2564","journal-title":"J Pathol"},{"key":"1716_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/PAS.0000000000001010","volume":"42","author":"CR Antonescu","year":"2018","unstructured":"Antonescu CR, Agaram NP, Sung YS, et al. A distinct malignant epithelioid neoplasm with GLI1 gene rearrangements, frequent S100 protein expression, and metastatic potential: expanding the spectrum of pathologic entities with ACTB\/MALAT1\/PTCH1-GLI1 fusions. Am J Surg Pathol. 2018;42:553\u201360. https:\/\/doi.org\/10.1097\/PAS.0000000000001010","journal-title":"Am J Surg Pathol"},{"key":"1716_CR14","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1097\/PAS.0000000000001360","volume":"43","author":"DA Kerr","year":"2019","unstructured":"Kerr DA, Pinto A, Subhawong TK, et al. Pericytoma with t(7;12) and ACTB-GLI1 fusion: reevaluation of an unusual entity and its relationship to the spectrum of GLI1 fusion-related neoplasms. Am J Surg Pathol. 2019;43:1682\u201392. https:\/\/doi.org\/10.1097\/PAS.0000000000001360","journal-title":"Am J Surg Pathol"},{"key":"1716_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/PGP.0000000000000542","volume":"38","author":"NWC Koh","year":"2019","unstructured":"Koh NWC, Seow WY, Lee YT, et al. Pericytoma with t(7;12): the first ovarian case reported and a review of the literature. Int J Gynecol Pathol. 2019;38:479\u201384. https:\/\/doi.org\/10.1097\/PGP.0000000000000542","journal-title":"Int J Gynecol Pathol"},{"key":"1716_CR16","doi-asserted-by":"publisher","unstructured":"Brahmi M, Franceschi T, Treilleux I, et al. Molecular classification of endometrial stromal sarcomas using RNA sequencing defines nosological and prognostic subgroups with different natural history. Cancers (Basel). 2020;12. https:\/\/doi.org\/10.3390\/cancers12092604","DOI":"10.3390\/cancers12092604"},{"key":"1716_CR17","doi-asserted-by":"publisher","first-page":"998","DOI":"10.6004\/jnccn.2021.7058","volume":"19","author":"RR Alwaqfi","year":"2021","unstructured":"Alwaqfi RR, Samuelson MI, Guseva NN, et al. PTCH1-GLI1 fusion-positive ovarian tumor: report of a unique case with response to tyrosine kinase inhibitor pazopanib. J Natl Compr Canc Netw. 2021;19:998\u20131004. https:\/\/doi.org\/10.6004\/jnccn.2021.7058","journal-title":"J Natl Compr Canc Netw"},{"key":"1716_CR18","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/his.14785","volume":"81","author":"L Hui","year":"2022","unstructured":"Hui L, Bai Q, Yang W, et al. GLI1-rearranged mesenchymal tumor in the ovary. Histopathology. 2022;81:688\u201392. https:\/\/doi.org\/10.1111\/his.14785","journal-title":"Histopathology"},{"key":"1716_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/gcc.23099","volume":"62","author":"LS Punjabi","year":"2023","unstructured":"Punjabi LS, Goh CHR, Sittampalam K. Expanding the spectrum of GLI1-altered mesenchymal tumors-A high-grade uterine sarcoma harboring a novel PAMR1::GLI1 fusion and literature review of GLI1-altered mesenchymal neoplasms of the gynecologic tract. Genes Chromosomes Cancer. 2023;62:107\u201314. https:\/\/doi.org\/10.1002\/gcc.23099","journal-title":"Genes Chromosomes Cancer"},{"key":"1716_CR20","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/s41588-021-00951-7","volume":"53","author":"C Rosswog","year":"2021","unstructured":"Rosswog C, Bartenhagen C, Welte A, et al. Chromothripsis followed by circular recombination drives oncogene amplification in human cancer. Nat Genet. 2021;53:1673\u201385. https:\/\/doi.org\/10.1038\/s41588-021-00951-7","journal-title":"Nat Genet"},{"key":"1716_CR21","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1093\/carcin\/bgi130","volume":"26","author":"X Ma","year":"2005","unstructured":"Ma X, Chen K, Huang S, et al. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis. 2005;26:1698\u2013705. https:\/\/doi.org\/10.1093\/carcin\/bgi130","journal-title":"Carcinogenesis"},{"key":"1716_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/path.4730","volume":"239","author":"L Spans","year":"2016","unstructured":"Spans L, Fletcher CD, Antonescu CR, et al. Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma. J Pathol. 2016;239:335\u201343. https:\/\/doi.org\/10.1002\/path.4730","journal-title":"J Pathol"},{"key":"1716_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.4251\/wjgo.v13.i5.409","volume":"13","author":"ME Arslan","year":"2021","unstructured":"Arslan ME, Li H, Fu Z, et al. Plexiform fibromyxoma: review of rare mesenchymal gastric neoplasm and its differential diagnosis. World J Gastrointest Oncol. 2021;13:409\u201323. https:\/\/doi.org\/10.4251\/wjgo.v13.i5.409","journal-title":"World J Gastrointest Oncol"},{"key":"1716_CR24","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/modpathol.2017.68","volume":"30","author":"RP Graham","year":"2017","unstructured":"Graham RP, Nair AA, Davila JI, et al. Gastroblastoma harbors a recurrent somatic MALAT1-GLI1 fusion gene. Mod Pathol. 2017;30:1443\u201352. https:\/\/doi.org\/10.1038\/modpathol.2017.68","journal-title":"Mod Pathol"},{"key":"1716_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/PAS.0000000000001439","volume":"44","author":"B Xu","year":"2020","unstructured":"Xu B, Chang K, Folpe AL, et al. Head and neck mesenchymal neoplasms with GLI1 gene alterations: a pathologic entity with distinct histologic features and potential for distant metastasis. Am J Surg Pathol. 2020;44:729\u201337. https:\/\/doi.org\/10.1097\/PAS.0000000000001439","journal-title":"Am J Surg Pathol"},{"key":"1716_CR26","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1097\/PAS.0000000000002272","volume":"48","author":"C Saoud","year":"2024","unstructured":"Saoud C, Agaimy A, Dermawan JK, et al. A comprehensive clinicopathologic and molecular reappraisal of GLI1 -altered mesenchymal tumors with pooled outcome analysis showing poor survival in GLI1 - amplified versus GLI1- rearranged tumors. Am J Surg Pathol. 2024;48:1302\u201317. https:\/\/doi.org\/10.1097\/PAS.0000000000002272","journal-title":"Am J Surg Pathol"},{"key":"1716_CR27","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/PGP.0000000000001026","volume":"43","author":"KM Vroobel","year":"2024","unstructured":"Vroobel KM, Khalid S, Cavalchini S, et al. A novel EPC1:: KDM2B fusion in high-grade endometrial stromal sarcoma. Int J Gynecol Pathol. 2024;43:612\u20136. https:\/\/doi.org\/10.1097\/PGP.0000000000001026","journal-title":"Int J Gynecol Pathol"},{"key":"1716_CR28","doi-asserted-by":"publisher","unstructured":"Ricotta G, Russo SA, Fagotti A, et al. Endometrial stromal sarcoma: an update. Cancers (Basel). 2025;17. https:\/\/doi.org\/10.3390\/cancers17111893","DOI":"10.3390\/cancers17111893"},{"key":"1716_CR29","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/modpathol.2017.162","volume":"31","author":"N Lewis","year":"2018","unstructured":"Lewis N, Soslow RA, Delair DF, et al. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity. Mod Pathol. 2018;31:674\u201384. https:\/\/doi.org\/10.1038\/modpathol.2017.162","journal-title":"Mod Pathol"},{"key":"1716_CR30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/cjp2.165","volume":"6","author":"FK Kommoss","year":"2020","unstructured":"Kommoss FK, Chang KT, Stichel D, et al. Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications. J Pathol Clin Res. 2020;6:178\u201384. https:\/\/doi.org\/10.1002\/cjp2.165","journal-title":"J Pathol Clin Res"},{"key":"1716_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ygyno.2020.02.024","volume":"157","author":"DI Lin","year":"2020","unstructured":"Lin DI, Hemmerich A, Edgerly C, et al. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss. Gynecol Oncol. 2020;157:357\u201366. https:\/\/doi.org\/10.1016\/j.ygyno.2020.02.024","journal-title":"Gynecol Oncol"},{"key":"1716_CR32","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1097\/PAS.0000000000001909","volume":"46","author":"FKF Kommoss","year":"2022","unstructured":"Kommoss FKF, Chiang S, Kobel M, et al. Endometrial stromal sarcomas with BCOR internal tandem duplication and variant BCOR\/BCORL1 rearrangements resemble high-grade endometrial stromal sarcomas with recurrent CDK4 pathway alterations and MDM2 amplifications. Am J Surg Pathol. 2022;46:1142\u201352. https:\/\/doi.org\/10.1097\/PAS.0000000000001909","journal-title":"Am J Surg Pathol"},{"key":"1716_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23051003","author":"M Didiasova","year":"2018","unstructured":"Didiasova M, Schaefer L, Wygrecka M. Targeting GLI transcription factors in cancer. Molecules 23. 2018. https:\/\/doi.org\/10.3390\/molecules23051003","journal-title":"Molecules 23"},{"key":"1716_CR34","doi-asserted-by":"publisher","unstructured":"Xie H, Paradise BD, Ma WW, et al. Recent advances in the clinical targeting of hedgehog\/gli signaling in cancer. Cells. 2019;8. https:\/\/doi.org\/10.3390\/cells8050394","DOI":"10.3390\/cells8050394"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01716-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01716-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01716-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T14:04:09Z","timestamp":1762437849000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01716-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1716"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01716-0","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were conducted in accordance with the ethical standards of Zhongshan Hospital, Fudan University and in accordance with the Declaration of Helsinki of 1975 (as revised in 2013). Informed consent was obtained from all individual participants included in the study. The study protocol was approved by the Ethics Committee of Zhongshan Hospital, Fudan University (Approval No. B2019-200R).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"This manuscript is original, has not been published elsewhere, and is not under consideration by any other publication. All authors have read and approved the final version of the manuscript and agree with its submission to Diagnostic Pathology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}